Julius Halaschek-Wiener

1.5k total citations
15 papers, 832 citations indexed

About

Julius Halaschek-Wiener is a scholar working on Molecular Biology, Oncology and Aging. According to data from OpenAlex, Julius Halaschek-Wiener has authored 15 papers receiving a total of 832 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Aging. Recurrent topics in Julius Halaschek-Wiener's work include Genetics, Aging, and Longevity in Model Organisms (4 papers), Cell death mechanisms and regulation (3 papers) and Cancer-related Molecular Pathways (3 papers). Julius Halaschek-Wiener is often cited by papers focused on Genetics, Aging, and Longevity in Model Organisms (4 papers), Cell death mechanisms and regulation (3 papers) and Cancer-related Molecular Pathways (3 papers). Julius Halaschek-Wiener collaborates with scholars based in Canada, Austria and Israel. Julius Halaschek-Wiener's co-authors include Angela Brooks‐Wilson, Burkhard Jansen, Yoel Kloog, Volker Wacheck, Marco A. Marra, Serge Przedborski, L. Deecke, Peter Teismann, Zorica Stević and Gabriele Almer and has published in prestigious journals such as PLoS ONE, Neurology and Genome Research.

In The Last Decade

Julius Halaschek-Wiener

15 papers receiving 812 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julius Halaschek-Wiener Canada 14 420 201 155 151 85 15 832
Esther Priel Israel 15 408 1.0× 87 0.4× 121 0.8× 256 1.7× 31 0.4× 39 720
John Canfield United States 11 354 0.8× 204 1.0× 77 0.5× 188 1.2× 14 0.2× 11 742
Haihui Pan United States 10 344 0.8× 82 0.4× 37 0.2× 103 0.7× 16 0.2× 12 641
Keisuke Yaku Japan 16 482 1.1× 33 0.2× 243 1.6× 232 1.5× 28 0.3× 32 1.1k
Lear E. Brace United States 10 712 1.7× 140 0.7× 115 0.7× 312 2.1× 36 0.4× 15 1.3k
Maria J. Rodríguez Colman Netherlands 16 797 1.9× 65 0.3× 281 1.8× 187 1.2× 27 0.3× 24 1.3k
Erich Birelli Tahara Brazil 13 684 1.6× 100 0.5× 34 0.2× 143 0.9× 32 0.4× 18 960
Lingtong Zhi China 16 424 1.0× 145 0.7× 249 1.6× 60 0.4× 5 0.1× 31 956
Jeffrey L. Staecker United States 10 472 1.1× 19 0.1× 89 0.6× 82 0.5× 78 0.9× 10 829
Teruaki Takasaki Japan 9 514 1.2× 207 1.0× 50 0.3× 27 0.2× 11 0.1× 25 636

Countries citing papers authored by Julius Halaschek-Wiener

Since Specialization
Citations

This map shows the geographic impact of Julius Halaschek-Wiener's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julius Halaschek-Wiener with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julius Halaschek-Wiener more than expected).

Fields of papers citing papers by Julius Halaschek-Wiener

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julius Halaschek-Wiener. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julius Halaschek-Wiener. The network helps show where Julius Halaschek-Wiener may publish in the future.

Co-authorship network of co-authors of Julius Halaschek-Wiener

This figure shows the co-authorship network connecting the top 25 collaborators of Julius Halaschek-Wiener. A scholar is included among the top collaborators of Julius Halaschek-Wiener based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julius Halaschek-Wiener. Julius Halaschek-Wiener is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Halaschek-Wiener, Julius, Lauren C. Tindale, Jennifer A. Collins, et al.. (2018). The Super-Seniors Study: Phenotypic characterization of a healthy 85+ population. PLoS ONE. 13(5). e0197578–e0197578. 14 indexed citations
2.
Richardson, Kathryn, Mila Tang, Julius Halaschek-Wiener, et al.. (2010). Genetic variation in carboxylesterase genes and susceptibility to isoniazid-induced hepatotoxicity. The Pharmacogenomics Journal. 10(6). 524–536. 43 indexed citations
3.
Halaschek-Wiener, Julius, Nasim Monfared, Christian Sailer, et al.. (2009). Genetic Variation in Healthy Oldest-Old. PLoS ONE. 4(8). e6641–e6641. 38 indexed citations
4.
Yamada, So, Mila Tang, Kathryn Richardson, et al.. (2009). Genetic Variations of NAT2 and CYP2E1 and Isoniazid Hepatotoxicity in a Diverse Population. Pharmacogenomics. 10(9). 1433–1445. 53 indexed citations
5.
Halaschek-Wiener, Julius, Irma Vulto, Daniel Fornika, et al.. (2008). Reduced telomere length variation in healthy oldest old. Mechanisms of Ageing and Development. 129(11). 638–641. 49 indexed citations
6.
Halaschek-Wiener, Julius & Angela Brooks‐Wilson. (2007). Progeria of Stem Cells: Stem Cell Exhaustion in Hutchinson-Gilford Progeria Syndrome. The Journals of Gerontology Series A. 62(1). 3–8. 74 indexed citations
7.
Halaschek-Wiener, Julius, Jaswinder Khattra, Sheldon McKay, et al.. (2005). Analysis of long-lived C. elegans daf-2 mutants using serial analysis of gene expression. Genome Research. 15(5). 603–615. 168 indexed citations
8.
Halaschek-Wiener, Julius, Volker Wacheck, Yoel Kloog, & Burkhard Jansen. (2004). Ras inhibition leads to transcriptional activation of p53 and down-regulation of Mdm2: two mechanisms that cooperatively increase p53 function in colon cancer cells. Cellular Signalling. 16(11). 1319–1327. 42 indexed citations
9.
Lucas, Trevor, Doris Losert, Matthew J. Allen, et al.. (2004). Combination Allele-Specific Real-Time PCR for Differentiation of β2-Adrenergic Receptor Coding Single-Nucleotide Polymorphisms. Clinical Chemistry. 50(4). 769–772. 7 indexed citations
10.
Halaschek-Wiener, Julius, Yoel Kloog, Volker Wacheck, & Burkhard Jansen. (2003). Farnesyl Thiosalicylic Acid Chemosensitizes Human Melanoma In Vivo. Journal of Investigative Dermatology. 120(1). 1–7. 42 indexed citations
11.
Almer, Gabriele, Peter Teismann, Zorica Stević, et al.. (2002). Increased levels of the pro-inflammatory prostaglandin PGE2 in CSF from ALS patients. Neurology. 58(8). 1277–1279. 112 indexed citations
12.
Gana‐Weisz, Mali, et al.. (2002). The Ras inhibitor S-trans,trans-farnesylthiosalicylic acid chemosensitizes human tumor cells without causing resistance.. PubMed. 8(2). 555–65. 62 indexed citations
13.
Wacheck, Volker, Elisabeth Heere‐Ress, Julius Halaschek-Wiener, et al.. (2001). Bcl-2 antisense oligonucleotides chemosensitize human gastric cancer in a SCID mouse xenotransplantation model. Journal of Molecular Medicine. 79(10). 587–593. 51 indexed citations
14.
Halaschek-Wiener, Julius, Volker Wacheck, Hermine Schlagbauer‐Wadl, et al.. (2000). A Novel Ras Antagonist Regulates Both Oncogenic Ras and the Tumor Suppressor p53 in Colon Cancer Cells. Molecular Medicine. 6(8). 693–704. 44 indexed citations
15.
Jansen, Burkhard, Elisabeth Heere‐Ress, Hermine Schlagbauer‐Wadl, et al.. (1999). Farnesylthiosalicylic acid inhibits the growth of human Merkel cell carcinoma in SCID mice. Journal of Molecular Medicine. 77(11). 792–797. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026